Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic trioxide plus vitamin C with salvage chemotherapy for relapsed or refractory B-cell non-Hodgkin lymphoma
ChiCTR-TRC-13003354Phase 2Completed
- Sponsor
- Department of Hematology, Second Affiliated Hospital of Dalian Medical University
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of arsenic trioxide and ascorbic acid in mature B-cell lymphoma (2 arms), sponsored by Department of Hematology, Second Affiliated Hospital of Dalian Medical University. Primary endpoints: Overall response rate, Overall survival and 1 more. Started Sep 2013; status: completed.
02
Drugs
arsenic trioxideascorbic acid
03
Conditions
mature B-cell lymphoma
Beyond the preview
Go deeper on ChiCTR-TRC-13003354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003354.